1 |
Janus kinases
(327 times)
|
Biochemistry (41 times)
|
STAT (60 times) STATs (49 times) IL-6 (22 times)
|
1995 Cytokine receptor signalling.
|
2 |
Janus tyrosine kinases
(21 times)
|
Biochemistry (7 times)
|
STATs (4 times) IL (3 times) STAT (3 times)
|
1995 Defective lymphoid development in mice lacking Jak3.
|
3 |
Janus family kinases
(15 times)
|
Allergy and Immunology (7 times)
|
IFN-gamma (3 times) BCR (1 time) CSF-1 (1 time)
|
1995 Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7.
|
4 |
Janus family of protein tyrosine kinases
(14 times)
|
Biochemistry (3 times)
|
IFN (2 times) IL (2 times) ALL (1 time)
|
1995 Characterization of a Stat-like DNA binding activity in Drosophila melanogaster.
|
5 |
Janus-associated kinases
(7 times)
|
Molecular Biology (4 times)
|
STAT3 (2 times) AD (1 time) APP (1 time)
|
1999 Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
|
6 |
Janus-activated kinases
(6 times)
|
Complementary Therapies (2 times)
|
STAT3 (3 times) BSN (1 time) HCC (1 time)
|
2008 Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signalling by the protein tyrosine phosphatase TCPTP.
|
7 |
Janus family of intracellular tyrosine kinases
(2 times)
|
Hematology (1 time)
|
MHC (1 time) SOCS (1 time) STATs (1 time)
|
1997 Thrombopoietin signal transduction in purified murine megakaryocytes.
|
8 |
JAK kinases
(1 time)
|
Molecular Biology (1 time)
|
IFNgamma (1 time) IL-6 (1 time) sIL-6R (1 time)
|
2000 The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
|
9 |
Janus family of cytoplasmic tyrosine kinases
(1 time)
|
Antineoplastic Agents (1 time)
|
STAT3 (1 time)
|
2018 Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells.
|
10 |
Janus kinase family of enzymes
(1 time)
|
Pharmacology (1 time)
|
AEs (1 time) RA (1 time)
|
2014 The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers.
|
11 |
Janus-family of activated kinases
(1 time)
|
Genetics, Medical (1 time)
|
MAPKs (1 time) PKC (1 time) ROS (1 time)
|
2001 High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
|